HighTower Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,233
Closed -$20.5K 3960
2024
Q4
$20.5K Sell
1,233
-2,001
-62% -$25K ﹤0.01% 3542
2024
Q3
$33K Sell
3,234
-266
-8% -$7.91K ﹤0.01% 3461
2024
Q2
$203K Sell
3,500
-241
-6% -$11.8K ﹤0.01% 3013
2024
Q1
$125K Sell
3,741
-1,815
-33% -$91.9K ﹤0.01% 3106
2023
Q4
$449K Sell
5,556
-68
-1% -$5.53K ﹤0.01% 2402
2023
Q3
$916K Buy
5,624
+1,653
+42% +$390K ﹤0.01% 1834
2023
Q2
$1.3M Buy
3,971
+6
+0.2% +$1.83K ﹤0.01% 1602
2023
Q1
$1.09M Sell
3,965
-41
-1% -$15.1K ﹤0.01% 1618
2022
Q4
$1.55M Sell
4,006
-20
-0.5% -$5.64K ﹤0.01% 1421
2022
Q3
$962K Buy
4,026
+680
+20% +$182K ﹤0.01% 1628
2022
Q2
$745K Buy
3,346
+94
+3% +$40.4K ﹤0.01% 1826
2022
Q1
$2.21M Buy
3,252
+15
+0.5% +$9.03K ﹤0.01% 1312
2021
Q4
$2.24M Buy
3,237
+10
+0.3% +$7.39K ﹤0.01% 1303
2021
Q3
$2.39M Buy
3,227
+239
+8% +$163K 0.01% 1164
2021
Q2
$2.24M Buy
2,988
+787
+36% +$602K 0.01% 1163
2021
Q1
$1.8M Buy
2,201
+319
+17% +$246K 0.01% 1186
2020
Q4
$1.6M Buy
1,882
+545
+41% +$420K 0.01% 1005
2020
Q3
$1M Buy
+1,337
New +$1.1M ﹤0.01% 1219

Other funds holding OM

HighTower Advisors's OM Position: Q1 2025 in Review

HighTower Advisors sold out of Outset Medical (OM) in Q1 2025, closing a stake of 1,233 shares — an estimated $20.5K sold.

HighTower Advisors first reported a position in OM in Q3 2020 and held it in 18 quarters. The position peaked at $2.39M in Q3 2021. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

  • HighTower Advisors reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 1,233 Outset Medical shares in Q1 2025, an estimated $20.5K.
  • HighTower Advisors first reported a position in Outset Medical in Q3 2020 and held it in 18 quarters.
  • HighTower Advisors's Outset Medical position peaked at $2.39M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.